{"cluster": 69, "subcluster": 63, "abstract_summ": " Many nonurgent surgeries are delayed to preserve hospital resources, and patient visits to health care settings are limited to reduce exposure to SARS-CoV-2 . For breast cancer, a key difference is increased use of neoadjuvant systemic therapy due to deferral of many breast surgeries ."}